These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16313047)

  • 1. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
    Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
    Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
    Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
    Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
    Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
    Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women.
    Missaoui N; Trabelsi A; Hmissa S; Fontanière B; Yacoubi MT; Mokni M; Korbi S; Frappart L
    Pathol Res Pract; 2010 Aug; 206(8):550-5. PubMed ID: 20400236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.
    Klaes R; Friedrich T; Spitkovsky D; Ridder R; Rudy W; Petry U; Dallenbach-Hellweg G; Schmidt D; von Knebel Doeberitz M
    Int J Cancer; 2001 Apr; 92(2):276-84. PubMed ID: 11291057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
    Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
    BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
    Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
    Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunct p16(INK4a) immunohistochemistry aids the detection of high-grade squamous intraepithelial lesions in endocervical curettage specimens.
    Shah AA; Jeffus SK; Zhao Z; Stoler MH; Stelow EB
    Am J Clin Pathol; 2014 Mar; 141(3):342-7. PubMed ID: 24515761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of the protein marker p16INK4a in the cervix uteri cancer].
    Volgareva GM; Zavalishina LE; Frank GA; Andreeva IuIu; Petrov AN; Kiselev FL; Spitkovskiĭ DD
    Arkh Patol; 2002; 64(1):22-4. PubMed ID: 11889694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells.
    Reuschenbach M; Seiz M; von Knebel Doeberitz C; Vinokurova S; Duwe A; Ridder R; Sartor H; Kommoss F; Schmidt D; von Knebel Doeberitz M
    Int J Cancer; 2012 Jan; 130(2):388-94. PubMed ID: 21387293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocervical glandular lesions: a diagnostic approach combining a semi-quantitative scoring method to the expression of CEA, MIB-1 and p16.
    Pavlakis K; Messini I; Athanassiadou S; Kyrodimou E; Pandazopoulou A; Vrekoussis T; Stathopoulos EN
    Gynecol Oncol; 2006 Dec; 103(3):971-6. PubMed ID: 16876235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16INK4A expression in cervical premalignant and malignant lesions.
    Lambert AP; Anschau F; Schmitt VM
    Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
    Tringler B; Gup CJ; Singh M; Groshong S; Shroyer AL; Heinz DE; Shroyer KR
    Hum Pathol; 2004 Jun; 35(6):689-96. PubMed ID: 15188135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of p16(INK4a) as a marker of clinical evolution in patients with cervical intraepithelial neoplasia grade 3 (CIN 3) treated by cervical conization.
    Cardoso FA; Campaner AB; Silva MA
    APMIS; 2014 Mar; 122(3):192-9. PubMed ID: 23763281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of flow cytometry for biomarker-based cervical cancer cells detection.
    Ling J; Wiederkehr U; Cabiness S; Shroyer KR; Robinson JP
    Diagn Cytopathol; 2008 Feb; 36(2):76-84. PubMed ID: 18181189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition of cervical carcinoma in situ to invasive cancer: role of p16 INK4a expression in progression and in recurrence.
    Anschau F; Schmitt VM; Lambert AP; Gonçalves MA; Machado DC
    Exp Mol Pathol; 2009 Feb; 86(1):46-50. PubMed ID: 19100258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.
    Lin Z; Gao M; Zhang X; Kim YS; Lee ES; Kim HK; Kim I
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):364-70. PubMed ID: 15785933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
    Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.